Axon price target raised to $735 from $726 at Barclays

Barclays raised the firm’s price target on Axon (AXON) to $735 from $726 and keeps an Overweight rating on the shares. The company’s strength continued with its 13th consecutive quarter of revenue growth over 25% year-over-year, the analyst tells investors in a research note. The firm says T10 demand continues to outpace current capacity.